1. Home
  2. BKD vs WGS Comparison

BKD vs WGS Comparison

Compare BKD & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookdale Senior Living Inc.

BKD

Brookdale Senior Living Inc.

HOLD

Current Price

$9.89

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$66.54

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKD
WGS
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
BKD
WGS
Price
$9.89
$66.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$19.08
★ $93.50
AVG Volume (30 Days)
★ 4.7M
739.2K
Earning Date
11-05-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.37
EPS
★ 0.07
N/A
Revenue
★ $4,531,426,000.00
$427,539,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
$2.55
$24.31
P/E Ratio
$143.43
★ N/A
Revenue Growth
N/A
★ 39.97
52 Week Low
$8.02
$32.21
52 Week High
$17.09
$170.87

Technical Indicators

Market Signals
Indicator
BKD
WGS
Relative Strength Index (RSI) 21.87 36.97
Support Level $9.74 $56.36
Resistance Level $14.36 $73.21
Average True Range (ATR) 0.36 4.58
MACD -0.03 -0.82
Stochastic Oscillator 6.93 15.85

Price Performance

Historical Comparison
BKD
WGS

About BKD Brookdale Senior Living Inc.

Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: